Neural cell repopulation is a powerful process in which damaged neurons are replaced with healthy cells. This type of regenerative medicine has great potential to restore neural function and treat a range of diseases. The process of neural cell repopulation involves transplanting healthy neural stem cells into the area of damage. This can be achieved with either an intraventricular or intracerebral approach. With the intraventricular method, immature stem cells are injected into the ventricles of the brain, where they then migrate to the area of damage. The intracerebral approach involves direct injection of healthy stem cells into the area of injury. Once neural stem cells reach the injured site, they differentiate into neurons, oligodendrocytes, and glial cells, the cells comprising the central nervous system. The new cells form connections that help restore communication between nerve cells and improve the functional capacity of the injured area. In animal models, neural cell repopulation has enabled some degree of recovery of function following injury. This suggests the potential for this treatment in humans, as well. Research is ongoing to better understand the therapeutic potential of neural cell repopulation and make it applicable to human clinical trials. However, there are still some obstacles to overcome. Specifically, the potential for these stem cells to form inappropriate neural connections or tumor formation must be considered. In addition, more research is needed to identify the ideal cellular mix of stem cells for successful repopulation. Neural cell repopulation is an exciting area of research, offering a potential solution for many diseases and conditions. Moving forward, further investigation and improvements in techniques will be required to realize the full potential of this therapeutic approach.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States